Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
7731 - 7740 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease
    Author(s): Luka Milosevic, Srdjan Sumarac, Daniel G. Di Luca, Carolina Ramirez‐Gomez, Mojgan Hodaie, William D. Hutchison, Suneil K. Kalia, Andrés M. Lozano, Anthony E. Lang, Alfonso Fasano
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 101
    Issue #:
    Start Page: 15
    End Page: 17
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.007
    Citation Count: 1
  • Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    2022
    Summary Details
    RESTRICTED
    Title: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Author(s): Jessica Joyce, Noel Cabanas, Rohan Pisharody, Bichun Ouyang, Roshni Patel, Jochen Reiser, Deborah J. Hall, Natalie Witek
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 101
    Issue #:
    Start Page: 39
    End Page: 42
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019
    Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.06.019
    Citation Count: 1
  • Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
    2022
    Summary Details
    OPEN
    Title: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
    Author(s): Norbert Kovács, József Attila Szász, Lydia Vela, Per Svenningsson, Samira Femia, Juan Carlos Parra, O. Sánchez-Soliño, Lars Bergmann, Tanya Gurevich, Alfonso Fasano
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 105
    Issue #:
    Start Page: 139
    End Page: 144
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002
    Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdf
    Citation Count: 10
  • Parkinson's Progression Markers Initiative brain autopsy program
    2022
    Summary Details
    RESTRICTED
    Title: Parkinson's Progression Markers Initiative brain autopsy program
    Author(s): Syed Bukhari, Kelly Nudelman, Malia Rumbaugh, Pema Richeson, Edward Fox, Kathleen S. Montine, Ibán Aldecoa, Alícia Garrido, Jonas Franz, Christine Stadelmann, Jean Paul Vonsattel, Kathleen L. Poston, Tatiana Foroud, Thomas J. Montine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 101
    Issue #:
    Start Page: 62
    End Page: 65
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.017
    Citation Count: 5
  • Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants
    2022
    Summary Details
    OPEN
    Title: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants
    Author(s): Vincent Beliveau, Christoph Müller, Ruth Steiger, Elke R. Gizewski, Werner Poewe, Klaus Seppi, Christoph Scherfler
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 101
    Issue #:
    Start Page: 43
    End Page: 48
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021
    Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdf
    Citation Count: 10
  • Heterogeneous pain trajectories in persons with Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Heterogeneous pain trajectories in persons with Parkinson's disease
    Author(s): Douglas Gunzler, Steven A. Gunzler, Farren Briggs
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 102
    Issue #:
    Start Page: 42
    End Page: 50
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.07.006
    Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.07.006
    Citation Count: 8
  • Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study
    2022
    Summary Details
    RESTRICTED
    Title: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study
    Author(s): Pavan A. Vaswani, James F. Morley, Danna Jennings, Andrew Siderowf, Kenneth Marek, Danna Jennings, Kenneth Marek, John Seibyl, Andrew Siderowf, Matthew Stern, David Russell, Kapil D. Sethi, Samuel Frank, Tanya Simuni, Robert A. Hauser, Bernard Ravina, Irene Richards, Grace Liang, Charles H. Adler, Rachel Saunders‐Pullman, Marian L. Evatt, Eugene C. Lai, Indu Subramanian, Penelope Hogarth, Kathryn A. Chung
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 104
    Issue #:
    Start Page: 15
    End Page: 20
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007
    Citation Count: 8
  • Chronotype, sleep, and sleepiness in Parkinson's disease
    2022
    Summary Details
    OPEN
    Title: Chronotype, sleep, and sleepiness in Parkinson's disease
    Author(s): Samantha Murphy, Lori B. Chibnik, Aleksandar Videnović
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 106
    Issue #:
    Start Page: 105189
    End Page: 105189
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011
    Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.10.011
    Citation Count: 8
  • The effect of limb selection methods on gait analysis in Parkinson's disease
    2022
    Summary Details
    OPEN
    Title: The effect of limb selection methods on gait analysis in Parkinson's disease
    Author(s): Sidney T. Baudendistel, Abigail C. Schmitt, Kate C Balthaser, Francesca E. Wade, Chris J. Hass
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 104
    Issue #:
    Start Page: 81
    End Page: 84
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013
    Citation Count: 2
  • Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    2022
    Summary Details
    RESTRICTED
    Title: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    Author(s): Jianhua Yang, Yuyuan Gao, Qingrui Duan, Yihui Qiu, Shujun Feng, Cuijing Zhan, Yin Huang, Yuhu Zhang, Guixian Ma, Kun Nie, Lijuan Wang
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 105
    Issue #:
    Start Page: 90
    End Page: 95
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019
    Citation Count: 15
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.